Company: INDP
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001493152-25-010136
Chunk: 457

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 1C
Chunk 457
---

do not make gross-up payments to cover our named executive officers’ personal income taxes that may pertain to any of the compensation
paid or provided by our company.

83

Outstanding
Equity Awards at Fiscal Year-End

The
following table sets forth information concerning outstanding option awards as of December 31, 2024, for each named executive officer:

Option
Awards

    Name
     
    Grant
    Date

    Number
    of Securities Underlying Unexercised
    Options Exercisable
    (#)

    Number
    of Securities Underlying Unexercised
    Options
    Unexercisable
    (#)

    Equity
    incentive
    plan awards: Number of
    securities
    underlying
    unexercised
    unearned
    options exercise price
    (#)

    Option
    Exercise Price
    ($)

    Option
    Expiration
    
    Date(1)

    Jeffrey
    A. Meckler, Chief Executive Officer
     
    04/10/17

    1,500

    —

    —

    425.6

    04/10/27

    05/01/17

    813

    —

    —

    425.6

    05/01/27

    12/11/17

    4,750

    —

    —

    536.0

    12/11/27

    06/28/18

    1,250

    —

    —

    355.2

    06/28/25

    04/04/19

    1,562

    —

    —

    611.2

    04/04/26

    07/15/20

    3,750

    —

    —

    24.6

    07/15/27

    08/04/21
     
    (2)

    375,000

    —

    —

    8.87

    8/4/2031

    01/26/22
     
    (3)

    183,333

    16,667

    —

    4.90

    01/26/32

    01/18/23
     
    (4)

    58,333

    41,667

    —